ArticleMolecular and clinical oncology2019

Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer.

Hidehiro Tajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.